No advantage of dexamethasone over predonisolone for the outcome of standard and intermediate risk childhood acute lymphoblastic leukemia in the Tokyo Children's Cancer Study group L95-14 protocol.
Bibliographic Information
- Title
- No advantage of dexamethasone over predonisolone for the outcome of standard and intermediate risk childhood acute lymphoblastic leukemia in the Tokyo Children's Cancer Study group L95-14 protocol.
- Author
- Igarashi S, Manabe A, Ohara A, Kumagai M, Saito T, Okimoto Y, Kamijo T, Isoyama K, Kajiwara M, Sotomatsu M, Sugita K, Sugita K, Maeda M, Yabe H, Kinoshita T, Kaneko T, Hayashi Y, Ikuta K, Hanada R, Tsuchiya M.
Journal
-
- J Clin Oncol 20
-
J Clin Oncol 20 6489-6498, 2005
- Tweet
Details
-
- CRID
- 1010282256862100244
-
- Article Type
- journal article
-
- Data Source
-
- KAKEN